Ocrevus 300 MG/1 ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9SN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,457
Award facts
- Contract value 100% obligated
- $38,456.55 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $38,456.55 to AmerisourceBergen Drug Corp for the supply of OCREVUS 300 mg/1 ml (ocrelizumab), a specialty pharmaceutical product used in the treatment of multiple sclerosis. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by January 9, 2026. The award was issued from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office operations.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion vehicle valued through December 31, 2031. This comprehensive IDC enables the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The competitively awarded contract vehicle demonstrates AmerisourceBergen's established capability to efficiently fulfill critical pharmaceutical supply requirements for military treatment facilities and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FW9SN?
SPE2DR26FW9SN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FW9SN worth?
The government has obligated $38,457 on SPE2DR26FW9SN.
Is contract SPE2DR26FW9SN an order under another contract?
Yes. SPE2DR26FW9SN is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9SN competed?
The extent of competition for SPE2DR26FW9SN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award